Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2010; 16(42): 5334-5341
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334
Figure 1 MK615 decreases receptor of advanced glycation end-product expression in HuH7 and HepG2 cells.
Cells were plated at 1 × 105/well in 24-well plates and then cultured for 24 h. MK615 was then added to the medium, followed by culture for a further 24 h. MK615 (0.1 μg/mL) decreased RAGE expression in both HuH7 (A-C) and HepG2 (D-F).
- Citation: Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T, Adachi M, Takino JI, Takeuchi M, Kubota K. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World J Gastroenterol 2010; 16(42): 5334-5341
- URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5334